Poland· PL-100177110

Trachisan 8 mg

A lidocaine product containing lidocaini hydrochloridum, registered in Poland by Engelhard Arzneimittel GmbH & Co. KG. The same ATC class is registered in 7 of our 19 countries.

ATC R02AD02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedTrachisan 8 mgATCR02AD02REGISTER NO.PL-100177110PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Lidocaine is registered in 7 of 19 countries.

Countries holding a registration under ATC R02AD02 (lidocaine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Lidocaine · ATC R02AD02

7 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Italyprice
  • Netherlands
  • Polandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Lidocaini hydrochloridum
Manufacturer
Engelhard Arzneimittel GmbH & Co. KG
Country
Poland (PL)
ATC code
R02AD02
ATC class
Lidocaine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909990053148

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

39 interactions on record for lidocaine.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Lidocaine · interactions on record

39 records

  • 1 severe
  • 38 moderate

Most severe, free to view

  • PrilocaineN01BB04severe
  • MetoclopramideA03FA01moderate
  • SulfamethizoleB05CA04moderate
  • Glyceryl trinitrateC01DA02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Lidocaine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lidocaine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Cathejell, Dynexan
  • Belgium · Instillido, Lidocaine Aguettant
  • Bulgaria · Instillido, Lidocaine Hydrochloride Monohydrate Чайкафарма
  • Cyprus · Lidocaine Apta, Lidocaine Hydrochloride Noridem
  • Czechia · Lidocain Egis, Lidocaine Egis
  • Germany · Acoin, Actilogic
  • Denmark · Instillido, Lidbree
  • Estonia · Instillido, Lidocaine Accord
  • Spain · Actilogic, Dermovagisil
  • Finland · Esliva, Instillido
  • France · Chlorhydrate De Lidocaine Renaudin, Dynexan
  • United Kingdom (Northern Ireland) · Boots Severe Sore Throat Relief, Chloradirect Severe Sore Throat Relief
  • Greece · Carmelido, Consolid
  • Croatia · Dolokain, Instillido
  • Hungary · Lidocain Egis, Lidocain-Egis
  • Ireland · Dolocopin, Lidocaine Hydrochloride
  • Iceland · Lidocaine Grindeks, Lidokain Viatris
  • Italy · Asensil, Basicaina
  • Liechtenstein · Lidocain Walter Ritter
  • Lithuania · Instillido, Lidocain-Egis
  • Luxembourg · Dynexan Gel, Lidocain Braun
  • Latvia · Lidocaine Baxter, Lidocaine Egis
  • Malta · Lidocaine Hydrochloride Bp B. Braun Melsungen, Lidonostrum
  • Netherlands · Dynexan Mondgel, Instillido
  • Norway · Instillido, Lidocaine Accord
  • Portugal · Lambdalina, Lidbree
  • Romania · Instillido, Lidocain
  • Sweden · Instillagel, Instillido
  • Slovenia · Instillido, Lidokain Kabi
  • Slovakia · Lidocain Egis, Lidocaine Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/086595e3-dbe1-4357-9d1c-0ecc89988d9c
GET /v1/drugs/086595e3-dbe1-4357-9d1c-0ecc89988d9c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pastylki",
  "source": "urpl",
  "strength": "8 mg",
  "packaging": "05909990053148 ¦ OTC ¦ 36250\n20 pastylek",
  "substance": "Lidocaini hydrochloridum 8 mg",
  "common_name": "Lidocaini hydrochloridum",
  "pl_product_id": "100177110",
  "pozwolenie_nr": "12945",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about lidocaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.